Cover Image
Market Research Report

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User - Global Forecasts to 2024

Published by MarketsandMarkets Product code 235782
Published Content info 229 Pages
Delivery time: 1-2 business days
Price
Back to Top
Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User - Global Forecasts to 2024
Published: August 23, 2018 Content info: 229 Pages
Description

"Global Next-generation Sequencing Market to Register a CAGR of 19.2% from 2018 to 2024"

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market. However, end-user budget constraints in developing nations are expected to restrain the growth of the next-generation sequencing market in the forecast period.

"Sequencing by Synthesis Segment to Dominate the NGS Market, by Technology, in 2018"

The next-generation sequencing market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing by synthesis segment is expected to command the largest share of the next-generation sequencing market in 2018. The large share of this segment can be attributed to the continuous advancements in SBS technology-based consumables and NGS bioinformatics solutions as well as the launch of advanced cost- & time-efficient platforms based on SBS technology.

"Hospitals & Clinics Segment to Register the Highest CAGR During 2018-2024"

On the basis of end user, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment is estimated to witness the highest growth rate during the forecast period. The high growth in this segment can be attributed to the development of advanced NGS-based diagnostic solutions and growing number of agreements between companies and hospitals for developing advanced tests and products catering to the specific needs of hospitals and clinics.

"The NGS Market in the APAC is Projected to Witness the Highest Growth Rate During the Forecast Period"

The next-generation sequencing market in the Asia Pacific is expected to witness the highest CAGR from 2018 to 2024. Factors such as increasing financial support from public as well as private agencies for NGS based research and diagnostics, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in the region are driving the growth of the next-generation sequencing market in the APAC region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 36%
  • By Designation: C-level - 43%, Director-level - 22%, and Others - 35%
  • By Region: North America - 37%, Europe - 12%, APAC - 41%, and RoW - 10%

The key players in the next-generation sequencing market are: Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

Research Coverage:

This report studies the next-generation sequencing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on business strategies adopted by the major players in the next-generation sequencing market. The report analyzes the next-generation sequencing market based on product & service, technology, application, end user, and region
  • Service Launches: Insights on the research and development activities and product & service launches in the next-generation sequencing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various next-generation sequencing types across regions
  • Market Diversification: Exhaustive information about recent developments, and investments in the next-generation sequencing market
  • Competitive Assessment: In-depth assessment of market ranking, strategies, and products of leading players in the next-generation sequencing market
Table of Contents
Product Code: BT 2697

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NEXT-GENERATION SEQUENCING (NGS): MARKET OVERVIEW
  • 4.2. NGS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2024
  • 4.3. NGS MARKET, BY TECHNOLOGY, 2018 VS. 2024(USD MILLION)
  • 4.4. NGS MARKET, BY APPLICATION, 2018 VS. 2024(USD MILLION)
  • 4.5. NGS MARKET, BY END USER AND REGION, 2018

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Advancements in NGS platforms
        • 5.2.1.1.1. iSeq
        • 5.2.1.1.2. Ion GeneStudio S5
      • 5.2.1.2. Declining costs
      • 5.2.1.3. Improving regulatory & reimbursement scenario for NGS-based diagnostic tests
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. End-user budget constraints in developing nations
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Initiatives from government & private bodies for large-scale sequencing projects
      • 5.2.3.2. Application of NGS in precision medicine & molecular diagnostics
      • 5.2.3.3. NGS data analysis using Big Data
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Interpretation of complex data from NGS platforms
      • 5.2.4.2. Ethical issues
    • 5.2.5. INDUSTRY TRENDS
      • 5.2.5.1. Reduction in platform footprint and the development of portable sequencing technology
      • 5.2.5.2. Partnerships and Collaborations for technological advancements in NGS
      • 5.2.5.3. Conferences and workshops increasing awareness on NGS products and services

6. NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. PRE-SEQUENCING PRODUCTS & SERVICES
    • 6.2.1. SAMPLE PREPARATION
      • 6.2.1.1. DNA fragmentation, end repair, A-tailing, and size selection
      • 6.2.1.2. Library preparation & target enrichment
      • 6.2.1.3. Quality control
  • 6.3. NGS CONSUMABLES, PLATFORMS, & SERVICES FOR PLATFORMS
    • 6.3.1. NGS CONSUMABLES
    • 6.3.2. NGS PLATFORMS
      • 6.3.2.1. Illumina
        • 6.3.2.1.1. HiSeq series
        • 6.3.2.1.2. HiSeq X ten & HiSeq X five
        • 6.3.2.1.3. MiSeq series
        • 6.3.2.1.4. NextSeq 500
        • 6.3.2.1.5. MiniSeq
        • 6.3.2.1.6. NovaSeq
      • 6.3.2.2. Thermo fisher scientific
        • 6.3.2.2.1. Ion PGM
        • 6.3.2.2.2. Ion proton
        • 6.3.2.2.3. Ion S5 & S5 XL
      • 6.3.2.3. Pacific biosciences
        • 6.3.2.3.1. PacBio RS II
        • 6.3.2.3.2. Sequel system
      • 6.3.2.4. Oxford nanopore technologies
      • 6.3.2.5. Other next-generation sequencing platforms
    • 6.3.3. SERVICES FOR NGS PLATFORMS
  • 6.4. SEQUENCING SERVICES
    • 6.4.1. EXOME & TARGETED RE-SEQUENCING AND CUSTOM PANELS
    • 6.4.2. RNA-SEQ
    • 6.4.3. WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING
    • 6.4.4. OTHER SEQUENCING SERVICES
  • 6.5. NGS DATA ANALYSIS, STORAGE, AND MANAGEMENT (BIOINFORMATICS)
    • 6.5.1. NGS DATA ANALYSIS SOFTWARE & WORKBENCHES
    • 6.5.2. NGS DATA ANALYSIS SERVICES
    • 6.5.3. NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS

7. NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING BY SYNTHESIS
  • 7.3. ION SEMICONDUCTOR SEQUENCING
  • 7.4. SINGLE-MOLECULE REAL-TIME SEQUENCING
  • 7.5. NANOPORE SEQUENCING
  • 7.6. OTHER SEQUENCING TECHNOLOGIES

8. NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. DIAGNOSTICS
    • 8.2.1. CANCER DIAGNOSTICS
    • 8.2.2. INFECTIOUS DISEASE DIAGNOSTICS
    • 8.2.3. REPRODUCTIVE HEALTH DIAGNOSTICS
    • 8.2.4. OTHER DIAGNOSTIC APPLICATIONS
  • 8.3. DRUG DISCOVERY
  • 8.4. AGRICULTURAL & ANIMAL RESEARCH
  • 8.5. OTHER APPLICATIONS

9. NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. ACADEMIC INSTITUTES & RESEARCH CENTERS
  • 9.3. HOSPITALS & CLINICS
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.5. OTHER END USERS

10. NEXT-GENERATION SEQUENCING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. SPAIN
    • 10.3.5. ITALY
    • 10.3.6. NETHERLANDS
    • 10.3.7. ROE
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND SERVICE LAUNCHES
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS
    • 11.3.3. MERGERS AND ACQUISITIONS
    • 11.3.4. EXPANSIONS

12. COMPANY PROFILE

  • 12.1. 10X GENOMICS
    • 12.1.1. BUSINESS OVERVIEW
    • 12.1.2. PRODUCTS OFFERED
    • 12.1.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.1.4. MNM VIEW
  • 12.2. AGILENT TECHNOLOGIES, INC.
    • 12.2.1. BUSINESS OVERVIEW
    • 12.2.2. PRODUCTS OFFERED
    • 12.2.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.2.4. MNM VIEW
  • 12.3. BECKMAN COULTER (A SUBSIDIARY OF DANAHER)
    • 12.3.1. BUSINESS OVERVIEW
    • 12.3.2. PRODUCTS OFFERED
    • 12.3.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.3.4. MNM VIEW
  • 12.4. BECTON, DICKINSON AND COMPANY
    • 12.4.1. BUSINESS OVERVIEW
    • 12.4.2. PRODUCTS OFFERED
    • 12.4.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.4.4. MNM VIEW
  • 12.5. BGI
    • 12.5.1. BUSINESS OVERVIEW
    • 12.5.2. PRODUCTS OFFERED
    • 12.5.3. SERVICES OFFERED
    • 12.5.4. MNM VIEW
  • 12.6. EUROFINS SCIENTIFIC
    • 12.6.1. BUSINESS OVERVIEW
    • 12.6.2. SERVICES OFFERED
    • 12.6.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.6.4. MNM VIEW
  • 12.7. F. HOFFMANN-LA ROCHE AG
    • 12.7.1. BUSINESS OVERVIEW
    • 12.7.2. PRODUCTS OFFERED
    • 12.7.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.7.4. MNM VIEW
  • 12.8. GENEWIZ
    • 12.8.1. BUSINESS OVERVIEW
    • 12.8.2. SERVICES OFFERED
    • 12.8.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.8.4. MNM VIEW
  • 12.9. ILLUMINA, INC.
    • 12.9.1. BUSINESS OVERVIEW
    • 12.9.2. PRODUCTS OFFERED
    • 12.9.3. SERVICES OFFERED
    • 12.9.4. RECENT DEVELOPMENTS (2015-2018)
    • 12.9.5. MNM VIEW
  • 12.10. MACROGEN, INC.
    • 12.10.1. BUSINESS OVERVIEW
    • 12.10.2. SERVICES OFFERED
    • 12.10.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.10.4. MNM VIEW
  • 12.11. OXFORD NANOPORE TECHNOLOGIES, LTD.
    • 12.11.1. BUSINESS OVERVIEW
    • 12.11.2. PRODUCTS OFFERED
    • 12.11.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.11.4. MNM VIEW
  • 12.12. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    • 12.12.1. BUSINESS OVERVIEW
    • 12.12.2. PRODUCTS OFFERED
    • 12.12.3. SERVICES OFFERED
    • 12.12.4. RECENT DEVELOPMENTS (2015-2018)
    • 12.12.5. MNM VIEW
  • 12.13. PERKINELMER, INC.
    • 12.13.1. BUSINESS OVERVIEW
    • 12.13.2. PRODUCTS & SERVICES OFFERED
    • 12.13.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.13.4. MNM VIEW
  • 12.14. THERMO FISHER SCIENTIFIC INC.
    • 12.14.1. BUSINESS OVERVIEW
    • 12.14.2. PRODUCTS AND SERVICES OFFERED
    • 12.14.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.14.4. MNM VIEW
  • 12.15. QIAGEN N.V.
    • 12.15.1. BUSINESS OVERVIEW
    • 12.15.2. PRODUCTS & SERVICES OFFERED
    • 12.15.3. RECENT DEVELOPMENTS (2015-2018)
    • 12.15.4. MNM VIEW

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NGS MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 2: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 3: NGS SAMPLE PREPARATION MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 4: DNA FRAGMENTATION, END REPAIR, A-TAILING, & SIZE SELECTION MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 5: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 6: QUALITY CONTROL MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 7: NGS PLATFORMS, CONSUMABLES, AND SERVICES FOR PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 8: NGS CONSUMABLES MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 9: NGS PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 10: NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 11: ILLUMINA NGS PLATFORMS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 12: ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 13: HISEQ SERIES PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 14: HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 15: MISEQ SERIES PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 16: NEXTSEQ 500 PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 17: MINISEQ PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 18: NOVASEQ PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 19: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 20: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 21: ION PGM PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 22: ION PROTON PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 23: ION S5 & S5 XL PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 24: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 25: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 26: PACBIO RS II PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 27: SEQUEL SYSTEM MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 28: OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 29: OTHER NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 30: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 31: SEQUENCING SERVICES MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 32: SEQUENCING SERVICES MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 33: NGS BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 34: NGS BIOINFORMATICS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 35: NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
  • TABLE 36: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 37: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 38: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 39: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 40: NANOPORE SEQUENCING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 41: OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 42: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 43: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 44: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 45: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 46: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 47: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 48: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 49: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 50: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 51: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 52: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 53: NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 55: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 56: NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 58: NORTH AMERICA: ILLUMINA PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 59: NORTH AMERICA: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 61: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 62: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 64: US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 65: CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 66: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 67: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 68: EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 69: EUROPE: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 70: EUROPE: ILLUMINA PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 71: EUROPE: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 72: EUROPE: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 73: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 74: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 75: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 76: GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 77: UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 78: FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 79: SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 80: ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 81: NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 82: ROE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 83: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 84: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 85: ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 86: ASIA PACIFIC: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 87: ASIA PACIFIC: ILLUMINA PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 88: ASIA PACIFIC: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 89: ASIA PACIFIC: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 90: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 91: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 92: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 93: CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 94: JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 95: INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 96: ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 97: ROW: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016-2024 (USD MILLION)
  • TABLE 98: ROW: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 99: ROW: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 100: ROW: ILLUMINA PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 101: ROW: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 102: ROW: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2016-2024 (USD MILLION)
  • TABLE 103: ROW: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 104: ROW: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 105: ROW: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 106: KEY LAUNCHES, PRODUCT ENHANCEMENTS, AND SERVICE LAUNCHES 2017-2018 (JULY)
  • TABLE 107: KEY FIVE AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2017-2018 (JULY)
  • TABLE 108: KEY MERGERS AND ACQUISITIONS, 2017-2018 (JULY)
  • TABLE 109: KEY GEOGRAPHIC EXPANSIONS, 2017-2018 (JULY)

LIST OF FIGURES

  • FIGURE 1: NEXT-GENERATION SEQUENCING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: NGS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: NGS PLATFORMS MARKET: BOTTOM-UP APPROACH
  • FIGURE 6: NGS MARKET: TOP-DOWN APPROACH
  • FIGURE 7: NGS MARKET: DATA TRIANGULATION
  • FIGURE 8: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2018 VS. 2024 (USD MILLION)
  • FIGURE 9: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2018 VS. 2024 (USD MILLION)
  • FIGURE 10: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
  • FIGURE 11: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2018 VS. 2024 (USD MILLION)
  • FIGURE 12: GEOGRAPHIC SNAPSHOT: NEXT-GENERATION SEQUENCING MARKET
  • FIGURE 13: NGS MARKET IS EXPECTED TO REGISTER A DOUBLE-DIGIT GROWTH RATE
  • FIGURE 14: CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE MAJOR SHARE DURING FORECAST PERIOD
  • FIGURE 15: SEQUENCING BY SYNTHESIS SEGMENT TO DOMINATE THE MARKET IN 2024
  • FIGURE 16: DIAGNOSTICS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE STUDY PERIOD
  • FIGURE 17: ACADEMIC INSTITUTES AND RESEARCH CENTERS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
  • FIGURE 18: NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2017
  • FIGURE 20: COMPARISON OF SYSTEM/PLATFORM COSTS, BY COMPANY
  • FIGURE 21: CONSUMABLES SEGMENT TO DOMINATE THE NEXT-GENERATION SEQUENCING MARKET IN 2018
  • FIGURE 22: NANOPORE SEQUENCING IS EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2018 TO 2024)
  • FIGURE 23: DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE NEXT-GENERATION SEQUENCING APPLICATIONS MARKET TILL 2024
  • FIGURE 24: CANCER DIAGNOSTICS TO DOMINATE THE NEXT-GENERATION SEQUENCING DIAGNOSTIC APPLICATIONS MARKET TILL 2024
  • FIGURE 25: FUNDING FOR CANCER RESEARCH FROM THE NATIONAL CANCER INSTITUTE (2016)
  • FIGURE 26: NUMBER OF PUBMED RESEARCH PUBLICATIONS ON NGS-BASED DRUG DISCOVERY, 2008-2017
  • FIGURE 27: HOSPITALS & CLINICS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE STUDY PERIOD
  • FIGURE 28: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 29: EUROPE: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 30: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 31: ROW: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 32: KEY DEVELOPMENTS IN THE NEXT-GENERATION SEQUENCING MARKET, JAN 2015 TO JULY 2018
  • FIGURE 33: NEXT-GENERATION SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 34: NEXT-GENERATION SEQUENCING PLATFORM MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 35: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
  • FIGURE 36: DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 37: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 38: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 39: ROCHE: COMPANY SNAPSHOT (2017)
  • FIGURE 40: ILLUMINA: COMPANY SNAPSHOT (2017)
  • FIGURE 41: PACIFIC BIOSCIENCES OF CALIFORNIA: COMPANY SNAPSHOT (2017)
  • FIGURE 42: PERKINELMER, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 43: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 44: QIAGEN N.V.: COMPANY SNAPSHOT (2017)
Back to Top